Classical Reporting System

Classical reporting system

Contexte	Official surveillance system relies on official laws. The Lebanese Law related to communicable diseases issued on the 31st December 1957 requests from physicians and healthcare facilities to report to the MOPH selected communicable diseases. On the other hand, the MOPH issues continuously decisions, circulars, and memos that specifies technical aspects of the national surveillance system (case definitions, forms…).
Objectives	- Measure disease burden and describe the characteristics. This includes: a) Measure incidence, prevalence, and mortality rates; b) Describe event/disease by time, place and person; c) Monitor trends; d) Identify high risk populations or areas; e) Identify risk factors; f) Evaluate specific diseases control programs. - Detect alerts and outbreaks. The detection of an outbreak gives an opportunity to investigate, find etiologies and implement corrective measures, thus aiming to reduce cases and prevent later outbreaks. Early warning and response system refers to the outbreak detection at early stages; when timely corrective measures can prevent additional new cases and stop the natural evolution of the outbreak.
Target diseases and syndromes	40 diseases and syndromes are targetted by the classical surveillance system. The diseases are displayed in 2 groups: immediate notification and weekly notification: - The immediate notifiable diseases and syndromes are: Acute Flaccid Paralysis, Anthrax, Cholera, Diphtheria, Food Poisoning, Hemorrhagic Fever, Influenza novel viruses, Invasive Coranaviruses, Measles, Meningitis, Meningococcal infection, Mumps, Pertussis, Plague, Rabies, Rubella and Congenital Rubella Syndrome, Smallpox, Tetanus including Tetanus Neonatorum, and Unusual Event - The weekly notifiable diseases and syndromes are: Bilharziasis, Brucellosis, Creutzfeldt-Jakob Disease (Transmissible Spongiform Encephalopathy), Gonococcal Infection,Hepatitis A, Hepatitis B, Hepatitis C, Hepatitis D, Hepatitis E, Human Immunodeficiency Virus, Human T-cell Lymphotropic Virus 1, Hydatid Disease, Intestinal Infections, Legionellosis, Leishmaniasis, Leprosy, Malaria, Syphilis, Tuberculosis, Typhoid Fever and Typhus.
Data Sources	All Physicians and Healthcare facilities
Guidelines	- Communicable diseases surveillance guideline: Ar, En - Communicable diseases surveillance standard operating procedures - part 1 (immediately notifiable diseases): En - Communicable diseases surveillance standard operating procedures - part 2 (weekly notifiable diseases): En
Case definitions	Refer to webpages "Notifiable Diseases"
Form	Reporting form
Results	Refer to webpage "Surveillance data"

...

194

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D11AH09	RUXOTOP	G	Ruxolitinib - 1.5%	1.5%	Cream	12,306,475 L.L
D11AX11	AVOQUIN	G	Hydroquinone - 4%	4%	Cream	916,501 L.L
D11AX11	JOLITE FORTE CREAM	G	Hydroquinone - 4%	4g/100g	Cream	612,792 L.L
D11AX16	FLOREXA	G	Eflornithine (HCl) - 11.5%	11.5%	Cream	3,527,587 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	2,154,180 L.L
D11AX22	SOOLANTRA	B	Ivermectin - 10mg/g	10mg/g	Cream	1,053,573 L.L
D01AC01	CANESTEN	B	Clotrimazole - 0.01g/g	0.01g/g	Cream	344,024 L.L
D01AC02	DAKTARIN	B	Miconazole nitrate - 20mg/g	20mg/g	Cream	231,141 L.L
D01AC03	ECONAZ	G	Econazole nitrate - 1%	1%	Cream	307,164 L.L
D01AC12	LOMEXIN	B	Fenticonazole nitrate - 2g/100g	2%	Cream	758,029 L.L
D01AC14	DERMOFIX	B	Sertaconazole nitrate - 20mg/g	2%	Cream	376,276 L.L
D01AE14	MYCOSTER	B	Ciclopirox - 1%	1%	Cream	325,210 L.L
D01AE15	LAMISIL	B	Terbinafine HCl - 10mg/g	1%	Cream	616,824 L.L
G01AF04	MYCODERM-V	G	Miconazole nitrate - 2%	2%	Cream	361,494 L.L
D01AE15	LAMIFEN	G	Terbinafine HCl - 1%	1%	Cream	350,743 L.L
D01AE15	LAMINOX	G	Terbinafine HCl - 10mg/g	10mg/g	Cream	453,067 L.L
D01AE15	TERAFAN	G	Terbinafine HCl - 1%	1%	Cream	499,142 L.L
D01AE15	TERMINUS	G	Terbinafine HCl - 1%	1%	Cream	747,176 L.L
D01AE22	EXODERIL	B	Naftifine HCl - 10mg/g	1%	Cream	345,368 L.L
D03AX	BEPANTHEN PLUS	B	Chlorhexidine HCl - 5mg/g, Dexpanthenol - 50mg/g		Cream	319,835 L.L
D04AA32	DERMAMINE ITCH STOPPING	G	Diphenhydramine HCl - 1%, Zinc acetete - 0.1%		Cream	560,382 L.L
D04AA32	HISTERGAN	G	Diphenhydramine HCl - 2%	2%	Cream	546,944 L.L
L01BC02	EFUDIX	B	Fluorouracil - 5%	5%	Cream	671,921 L.L
D04AX01	DOXIDERM	G	Doxepin (HCl) - 5%	5%	Cream	1,037,958 L.L
G03CA03	MONTADIOL	G	Estradiol - 0.01%	0.01%	Cream	1,105,982 L.L
D06AX01	FUCIDIN	B	Fusidic acid - 20mg/g	2%	Cream	259,362 L.L
M02AA15	CLOFEN	G	Diclofenac sodium (diethylamine) - 10mg/g	1%	Creamagel	206,952 L.L
S01AA12	TOBRACIN	G	Tobramycin - 0.3%	0.3%	Drops	322,522 L.L
S01AA12	TOBRIN	G	Tobramycin - 0.3%	0.3%	Drops	169,324 L.L
S01AA13	FUCITHALMIC VISCOUS	B	Fusidic acid - 10mg/g	1%	Drops	443,468 L.L

...

194